Loading...
•
Sep 30, 2024
Acadia Healthcare Q3 2024 Earnings Report
Acadia Healthcare reported strong financial results driven by the execution of its growth strategy and commitment to providing quality care.
Key Takeaways
Acadia Healthcare reported an 8.7% increase in revenue, totaling $815.6 million for Q3 2024. Net income attributable to Acadia was $68.1 million, or $0.74 per diluted share, while adjusted income was $84.1 million, or $0.91 per diluted share. The company is on track to expand its facilities and bed capacity.
Revenue totaled $815.6 million, an increase of 8.7% over the third quarter of 2023.
Same facility revenue increased 8.6% compared with the third quarter of 2023, including an increase in revenue per patient day of 3.6% and an increase in patient days of 4.7%.
Net income attributable to Acadia totaled $68.1 million, or $0.74 per diluted share.
Adjusted income attributable to Acadia totaled $84.1 million, or $0.91 per diluted share.
Forward Guidance
Acadia revised its financial guidance for 2024, anticipating revenue between $3.150 to $3.165 billion and adjusted earnings per diluted share between $3.35 and $3.45.
Positive Outlook
- Revenue between $3.150 to $3.165 billion.
- Adjusted EBITDA between $725 to $735 million.
- Adjusted earnings per diluted share between $3.35 to $3.45.
- Operating cash flows $525 to $550 million
- Total bed additions, excluding acquisitions approximately 1,200 beds
Challenges Ahead
- Interest expense $110 to $120 million
- Tax rate not specified
- Depreciation and amortization expense $145 to $155 million.
- Stock compensation expense $40 to $45 million.
- Expansion capital expenditures $550 to $595 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...